Fruttero R - Search Results

1

Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets.

Turnbull CM, Cena C, Fruttero R, Gasco A, Rossi AG, Megson IL. Turnbull CM, et al. Among authors: fruttero r. Br J Pharmacol. 2006 Jun;148(4):517-26. doi: 10.1038/sj.bjp.0706743. Epub 2006 May 15. Br J Pharmacol. 2006. PMID: 16702997 Free PMC article.

2

4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation.

Calvino R, Fruttero R, Ghigo D, Bosia A, Pescarmona GP, Gasco A. Calvino R, et al. Among authors: fruttero r. J Med Chem. 1992 Aug 21;35(17):3296-300. doi: 10.1021/jm00095a028. J Med Chem. 1992. PMID: 1324320

3

Characterization of a new compound, S35b, as a guanylate cyclase activator in human platelets.

Ghigo D, Heller R, Calvino R, Alessio P, Fruttero R, Gasco A, Bosia A, Pescarmona G. Ghigo D, et al. Among authors: fruttero r. Biochem Pharmacol. 1992 Mar 17;43(6):1281-8. doi: 10.1016/0006-2952(92)90504-c. Biochem Pharmacol. 1992. PMID: 1348617

4

S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells.

Heller R, Bussolino F, Calvino R, Ghigo D, Alessio P, Todde R, Fruttero R, Pescarmona G, Gasco A, Till U, et al. Heller R, et al. Among authors: fruttero r. Agents Actions. 1993 Nov;40(3-4):157-65. doi: 10.1007/BF01984055. Agents Actions. 1993. PMID: 7517616

5

A new class of furoxan derivatives as NO donors: mechanism of action and biological activity.

Ferioli R, Folco GC, Ferretti C, Gasco AM, Medana C, Fruttero R, Civelli M, Gasco A. Ferioli R, et al. Among authors: fruttero r. Br J Pharmacol. 1995 Feb;114(4):816-20. doi: 10.1111/j.1476-5381.1995.tb13277.x. Br J Pharmacol. 1995. PMID: 7773542 Free PMC article.

6

Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation.

Medana C, Ermondi G, Fruttero R, Di Stilo A, Ferretti C, Gasco A. Medana C, et al. Among authors: fruttero r. J Med Chem. 1994 Dec 9;37(25):4412-6. doi: 10.1021/jm00051a020. J Med Chem. 1994. PMID: 7996554

7

No-mimetic furoxans: arylsulphonylfuroxans and related compounds.

Ferioli R, Fazzini A, Folco GC, Fruttero R, Calvino R, Gasco A, Bongrani S, Civelli M. Ferioli R, et al. Among authors: fruttero r. Pharmacol Res. 1993 Oct-Nov;28(3):203-12. doi: 10.1006/phrs.1993.1123. Pharmacol Res. 1993. PMID: 8108310

8

Pharmacochemistry of the furoxan ring: recent developments.

Calvino R, Di Stilo A, Fruttero R, Gasco AM, Sorba G, Gasco A. Calvino R, et al. Among authors: fruttero r. Farmaco. 1993 Feb;48(2):321-34. Farmaco. 1993. PMID: 8388218

9

The furoxan system as a useful tool for balancing "hybrids" with mixed alpha 1-antagonist and NO-like vasodilator activities.

Fruttero R, Boschi D, Di Stilo A, Gasco A. Fruttero R, et al. J Med Chem. 1995 Dec 8;38(25):4944-9. doi: 10.1021/jm00025a012. J Med Chem. 1995. PMID: 8523408

10

No-donors: an emerging class of compounds in medicinal chemistry.

Gasco A, Fruttero R, Sorba G. Gasco A, et al. Among authors: fruttero r. Farmaco. 1996 Oct;51(10):617-35. Farmaco. 1996. PMID: 8981752 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters